AURORE LIFE SCIENCES PRIVATE LIMITED

Aurore Life Sciences, established in 2017, is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, offering high-quality, affordable bulk drug solutions to over 55 countries worldwide. With a pure-play focus on APIs and intermediates, Aurore is a fully backward-integrated pharmaceutical company dedicated to delivering to all regulated markets globally.

At the heart of our business model is complete backward integration, ensuring control over every stage of production—from raw materials to the final API. This streamlined process guarantees not only an uninterrupted supply chain but also enhances product consistency, quality, and cost-efficiency. By reducing our reliance on external suppliers, Aurore Life Sciences offers customers a reliable and uninterrupted supply of essential APIs and intermediates, positioning us as the preferred supplier of choice in the industry.

Our diverse product portfolio comprises over 60 APIs, more than 122 Drug Master Files (DMFs), and over 100 intermediates. Supported by state-of-the-art manufacturing facilities, we meet the evolving needs of pharmaceutical companies worldwide.